Atypical antipsychotic used for the treatment of acute and chronic schizophrenia, particularly effective for negative symptoms such as emotional blunting and social withdrawal; also exhibits anxiolytic and antidepressant effects, beneficial for patients with anxiety and lack of motivation; the decanoate ester formulation is a long-acting depot injection commonly used for maintenance therapy in chronic schizophrenia; shows potent dopamine D1/D2 receptor antagonism (Ki = 0.38 nM for D2) and 5-HT2A receptor affinity (Ki = 7 nM), contributing to its antipsychotic and antidepressant activities; demonstrated efficacy in reducing cocaine-induced hyperactivity in animal models.